Gerhard Nahler
Impact in
-
- Multiple Sclerosis Research Studies
- Neurology top 5%
- Peripheral Neuropathies and Disorders
Papers in
- Pharmacology 16
- Cannabis and Cannabinoid Research 16
- Co-authors
- Florian DeisenhammerSiegrid Strasser‐FuchsB. MamoliFranz FazekasRudolf LikarJosé Alexandre S. CrippaAntônio Waldo ZuardiFranjo Grotenhermen
- Journals
- Multiple Sclerosis Journal (2 papers)Anticancer Research (1 paper)Cannabis and Cannabinoid Research (1 paper)Journal of Neuroimmune Pharmacology (1 paper)Gynecologic and Obstetric Investigation (1 paper)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Gerhard Nahler
33 papers receiving 666 citations
Peers
Comparison fields: 5 of 136
- Pathology and Forensic Medicine 255
- Neurology 200
- Pharmacology 177
- Hematology 70
- Immunology 113
Countries citing papers authored by Gerhard Nahler
This map shows the geographic impact of Gerhard Nahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Nahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Nahler more than expected).
Fields of papers citing papers by Gerhard Nahler
This network shows the impact of papers produced by Gerhard Nahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Nahler. The network helps show where Gerhard Nahler may publish in the future.
Co-authors
The 22 scholars most cited alongside Gerhard Nahler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 29 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 32 | |
| 11 | 2019 | 27 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 8 | |
| 14 | 2017 | 38 | |
| 15 | 2000 | 14 | |
| 16 | 1997 | 295 | |
| 17 | [Hormonal status of the woman and its effect on symptoms and progression of chronic polyarthritis]. | 1996 | 0 |
| 18 | 1989 | 16 | |
| 19 | 1979 | 8 | |
| 20 | [Membranes of glyoxysomes from castor bean endosperm: further investigations on the membrane bound enzymes of fatty acid degradation and of the glyoxylate cycle]. | 1974 | 3 |
About Gerhard Nahler
Gerhard Nahler is a scholar working on Pharmacology, Toxicology, Applied Microbiology and Biotechnology, Endocrinology and Neurology, having authored 37 papers that have together received 705 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (16 papers), Peripheral Neuropathies and Disorders (4 papers), Multiple Sclerosis Research Studies (4 papers), Diet, Metabolism, and Disease (3 papers), PARP inhibition in cancer therapy (3 papers), Glioma Diagnosis and Treatment (2 papers), Lipid metabolism and biosynthesis (2 papers) and Pediatric Urology and Nephrology Studies (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (255 citations), Neurology (200 citations), Pharmacology (177 citations), Hematology (70 citations) and Immunology (113 citations). Gerhard Nahler has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Florian Deisenhammer, Siegrid Strasser‐Fuchs, B. Mamoli, Franz Fazekas, Rudolf Likar, José Alexandre S. Crippa, Antônio Waldo Zuardi, Franjo Grotenhermen, Martin Stultschnig and Guido Müller. Their work appears in journals such as Multiple Sclerosis Journal, Anticancer Research, Cannabis and Cannabinoid Research, Journal of Neuroimmune Pharmacology and Gynecologic and Obstetric Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.